DOCSLIB.ORG

Biological Markers for Anxiety Disorders, OCD and PTSD: a Consensus Statement

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biological Markers for Anxiety Disorders, OCD and PTSD: a Consensus Statement Europe PMC Funders Group Author Manuscript World J Biol Psychiatry. Author manuscript; available in PMC 2017 April 01. Published in final edited form as: World J Biol Psychiatry. 2017 April ; 18(3): 162–214. doi:10.1080/15622975.2016.1190867. Europe PMC Funders Author Manuscripts Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition Borwin Bandelowa, David Baldwinb, Marianna Abellic, Blanca Bolea-Alamanaci, Michel Bourine, Samuel R. Chamberlainf,g, Eduardo Cinosih, Simon Daviesd,i, Katharina Domschkej, Naomi Finebergf, Edna Grünblattj,k,l,m, Marek Jareman, Yong-Ku Kimo, Eduard Maronp,q,t, Vasileios Masdrakisr, Olya Mikovas, David Nuttt, Stefano Pallantiu, Stefano Pinic, Andreas Ströhlev, Florence Thibautw, Matilde M. Vaghixx, Eunsoo Wono, Dirk Wedekinda, Adam Wichniakn, Jade Woolleyb, Peter Zwanzgery,z, and Peter Riedererj aDepartment of Psychiatry and Psychotherapy, University of Göttingen, Germany bFaculty of Medicine, University of Southampton, Southampton, UK cDepartment of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy dCentre for Addiction and Mental Health, Geriatric Psychiatry Division, University of Toronto, Toronto, Canada eNeurobiology of Anxiety and Mood Disorders, University of Nantes, Nantes, France fHertfordshire Partnership University NHS Foundation Trust and University of Hertfordshire, Parkway, UK gDepartment of Psychiatry, University of Cambridge, Cambridge, UK hDepartment of Neuroscience Imaging and Clinical Sciences, Gabriele D’Annunzio University, Chieti, Italy iSchool Europe PMC Funders Author Manuscripts of Social and Community Medicine, Academic Unit of Psychiatry, University of Bristol, Bristol, UK jDepartment of Psychiatry Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany kDepartment of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland lNeuroscience Center Zurich, University of Zurich and the ETH Zurich, Zurich, Switzerland mZurich Center for Integrative CONTACT Prof. Dr. Borwin Bandelow [email protected] von-Siebold-Str. 5, Department of Psychiatry and Psychotherapy, University of Göttingen D-37075 Göttingen, Germany. All other authors reported no conflicts of interest to declare. ORCID Borwin Bandelow http://orcid.org/0000-0003-2511-3768 Marianna Abelli http://orcid.org/0000-0002-3877-7048 Michel Bourin http://orcid.org/0000-0002-7268-4590 Samuel R. Chamberlain http://orcid.org/0000-0001-7014-8121 Eduardo Cinosi http://orcid.org/0000-0002-8903-181X Naomi Fineberg http://orcid.org/0000-0003-1158-6900 Edna Grünblatt http://orcid.org/0000-0001-8505-7265 Marek Jarema http://orcid.org/0000-0001-5267-5315 Yong-Ku Kim http://orcid.org/0000-0001-5694-7840 Vasileios Masdrakis http://orcid.org/0000-0003-0197-9583 David Nutt http://orcid.org/0000-0002-1286-1401 Stefano Pallanti http://orcid.org/0000-0001-5828-4868 Stefano Pini http://orcid.org/0000-0001-9092-9144 Florence Thibaut http://orcid.org/0000-0002-0204-5435 Matilde M. Vaghi http://orcid.org/0000-0002-0999-9055 Eunsoo Won http://orcid.org/0000-0001-6825-032X Peter Zwanzger http://orcid.org/0000-0002-5385-8188 Bandelow et al. Page 2 Human Physiology, University of Zurich, Zurich, Switzerland nThird Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland oDepartment of Psychiatry College of Medicine, Korea University, Seoul, Republic of Korea pDepartment of Psychiatry, North Estonia Medical Centre, Tallinn, Estonia qDepartment of Psychiatry, University of Tartu, Estonia rAthens Europe PMC Funders Author Manuscripts University Medical School, First Department of Psychiatry, Eginition Hospital, Athens, Greece sFoundation Biological Psychiatry, Sofia, Bulgaria tFaculty of Medicine Department of Medicine, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK uUC Davis Department of Psychiatry and Behavioural Sciences, Sacramento, CA, USA vDepartment of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité – University Medica Center Berlin, Berlin, Germany wFaculty of Medicine Paris Descartes, University Hospital Cochin, Paris, France xDepartment of Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK ykbo-Inn-Salzach-Klinikum Wasserburg am Inn, Germany zDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany Abstract Objective—Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Methods—Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network. Europe PMC Funders Author Manuscripts Results—The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions—Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD. Keywords Anxiety disorders; neuroimaging; genetic; neurochemistry; neurobiology; review Introduction This consensus statement on biological markers of anxiety disorders was organised by members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the Anxiety Disorders Research Network (ADRN) within the World J Biol Psychiatry. Author manuscript; available in PMC 2017 April 01. Bandelow et al. Page 3 European College of Neuropsychopharmacology Network Initiative (ECNP-NI; Baldwin et al. 2010), an initiative intended to meet the goal of extending current understanding of the causes of central nervous system (CNS) disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. Europe PMC Funders Author Manuscripts The present article (Part II) summarises the findings on potential biomarkers in neurochemistry, neurophysiology, and neurocognition. Part I (Bandelow et al. 2016) focuses on neuroimaging and genetics. Neurochemistry Plasma appears to be a rational source for proteomic and metabolomic measurements in psychiatric conditions because it is easily accessible, and several molecules from the brain are transported across the blood–brain barrier and reach the peripheral circulation. However, it is difficult to draw inferences from the neurochemical composition of plasma on the situation in brain cells. Lumbar puncture is an invasive method, and the composition of cerebrospinal fluid (CSF) does not reflect exactly the neurochemistry in brain cells. Nevertheless, as a biomarker measure, such recourses are highly valuable, and several examples of evidence in the literature points to possible links between CNS and periphery. In the following sections, some of these findings are listed and described. Neurotransmitters Monoaminergic systems have long been suggested to play a major role in depression and anxiety disorders. While the “reward system” is modulated by endogenous dopamine and opioids (Barbano & Cador 2007; Berridge & Aldridge 2008; Le Merrer et al. 2009; Bandelow & Wedekind 2015), the “punishment system” is mainly driven by serotonin (5- Europe PMC Funders Author Manuscripts HT; Stein 1971; Daw et al. 2002). Goal-directed behaviours are stimulated by dopamine (DA), and dopamine neurons have been suggested to be a substrate for intracranial self- stimulation (Wise & Bozarth 1982; Mason & Angel 1984; Aboitiz 2009). Norepinephrine (noradrenaline; NE) has been connected to “emotional memory” and the consolidation and retrieval of the emotional arousal induced by particular behaviours (van Praag et al. 1990; Goddard et al. 2010). NE neurons regulate vulnerability to social defeat through inhibitory control of ventral tegmental area DA neurones (Isingrini et al. 2016). Serotonergic system—Findings on brain imaging and genetics of the serotonin system are summarised in Part I (Bandelow et al. 2016). 5-HT is a monoamine, found in the CNS, in blood platelets, and the gastrointestinal tract. The principal source of serotonin release in the brain are the raphe nuclei in the brainstem. They are hypothesised to have a dual role in aversive contingencies (Deakin & Graeff 1991; Deakin 2013). 5-HT can inhibit periaqueductal grey matter-medicated fight/flight responses from threats, while it can also facilitate amygdala-mediated anxiety responses. The latter mechanism has been demonstrated both in animals (Deakin & Graeff 1991; Deakin 2013) and humans (Blanchard et al. 2001; Mobbs et al. 2007; Feinstein et al. 2013). Such differences may explain partly
Load more

Recommended publications
  • Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective
    Europäisches Patentamt *EP001336602A1* (19) European Patent Office Office européen des brevets (11) EP 1 336 602 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: C07C 205/00, A61K 31/00 20.08.2003 Bulletin 2003/34 (21) Application number: 02425075.5 (22) Date of filing: 13.02.2002 (84) Designated Contracting States: (71) Applicant: Scaramuzzino, Giovanni AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU 20052 Monza (Milano) (IT) MC NL PT SE TR Designated Extension States: (72) Inventor: Scaramuzzino, Giovanni AL LT LV MK RO SI 20052 Monza (Milano) (IT) (54) Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases (57) New pharmaceutical compounds of general effects and for this reason they are useful for the prep- formula (I): F-(X)q where q is an integer from 1 to 5, pref- aration of medicines for prevention and treatment of in- erably 1; -F is chosen among drugs described in the text, flammatory, ischemic, degenerative and proliferative -X is chosen among 4 groups -M, -T, -V and -Y as de- diseases of musculoskeletal, tegumental, respiratory, scribed in the text. gastrointestinal, genito-urinary and central nervous sys- The compounds of general formula (I) are nitrate tems. prodrugs which can release nitric oxide in vivo in a con- trolled and selective way and without hypotensive side EP 1 336 602 A1 Printed by Jouve, 75001 PARIS (FR) EP 1 336 602 A1 Description [0001] The present invention relates to new nitrate prodrugs which can release nitric oxide in vivo in a controlled and selective way and without the side effects typical of nitrate vasodilators drugs.
    [Show full text]
  • 4695389.Pdf (3.200Mb)
    Non-classical amine recognition evolved in a large clade of olfactory receptors The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Li, Qian, Yaw Tachie-Baffour, Zhikai Liu, Maude W Baldwin, Andrew C Kruse, and Stephen D Liberles. 2015. “Non-classical amine recognition evolved in a large clade of olfactory receptors.” eLife 4 (1): e10441. doi:10.7554/eLife.10441. http://dx.doi.org/10.7554/ eLife.10441. Published Version doi:10.7554/eLife.10441 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:23993622 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA RESEARCH ARTICLE Non-classical amine recognition evolved in a large clade of olfactory receptors Qian Li1, Yaw Tachie-Baffour1, Zhikai Liu1, Maude W Baldwin2, Andrew C Kruse3, Stephen D Liberles1* 1Department of Cell Biology, Harvard Medical School, Boston, United States; 2Department of Organismic and Evolutionary Biology, Museum of Comparative Zoology, Harvard University, Cambridge, United States; 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States Abstract Biogenic amines are important signaling molecules, and the structural basis for their recognition by G Protein-Coupled Receptors (GPCRs) is well understood. Amines are also potent odors, with some activating olfactory trace amine-associated receptors (TAARs). Here, we report that teleost TAARs evolved a new way to recognize amines in a non-classical orientation.
    [Show full text]
  • Thank You for Investing in SILS
    1 Thank you for investing in SILS SILS is pleased to recognize and honor the following donors for their generous support. Much of what SILS is, and what we hope to be in the future, is the result of private support. Your gifts help SILS recruit and educate talented student as well as preeminent faculty. Private support also helps spark new initiatives as well as sustain current areas of scholarship and research. This listing reflects gifts to SILS, received between July 1, 2010 and June 30, 2011. Andrea Louise Rohrbacher '90 Mabel Marie Shaw '85 Legacy Society ($1M +) no donors Kim Lee Bartholomew '00 and William Cary Sibert Jr. '99 Duncan Franklin Smith '76, '80 Elizabeth Anne Bartlett '89 John Ray Turbyfill Jr.'88 Alice Lee Googe Bauer '38 Louis Round Wilson Society ($100,000- Edith E. Yakutis and Leo Yakutis '88, '91 Jeffrey Beall '90 999,999) Patricia Warren Becker '59 Duke University Associates ($250-499) Jean Maragert Robinson Beecher '74 Larry Paul Alford '73 and '78 Peggy White Bellamy '67 Joan Nancy Bardez '68 David B. Bennett '87 Susan Grey Akers Affiliates ($50,000-99,999) Philip Mathews Cheney '77 Sylvia Cratch Bennett '80 no donors Evelyn Hope Daniel Susan Ruth Percy Benning '89 Michol Dawson '99, '03 and David O. Amuda '03 Dale Monroe Bentz '40 Fannie Jones Dillard '76, '78 and Tom Dillard Jr. '77 Lucille K. Henderson Affiliates ($10,000-49,999) Damien Mario Berahzer '05 Baker & Taylor Susan Dillard Donkar '73, '75 Laura Jeanne Berberian '08 IBM Corporation Kevin Timothy Doupe '01 Marcia Hall Bethea '87 Eleanor M.
    [Show full text]
  • Tachykinins and Airway Microvascular Leakage Induced by Hcl Intra-Oesophageal Instillation
    Copyright #ERS Journals Ltd 2002 Eur Respir J 2002; 20: 268–273 European Respiratory Journal DOI: 10.1183/09031936.02.00250902 ISSN 0903-1936 Printed in UK – all rights reserved Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation S. Daoui*,B.D9Agostino#, L. Gallelli#, X. Emonds Alt}, F. Rossi#, C. Advenier* Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal *Dept of Pharmacology, University instillation. S. Daoui, B. D9Agostino, L. Gallelli, X. Emonds Alt, F. Rossi, C. Advenier. Paris V, Paris, France, #Dept of #ERS Journals Ltd 2002. Experimental Medicine, Faculty of ABSTRACT: Gastro-oesophageal reflux is a common clinical disorder associated with Medicine and Surgery, Naples, Italy, }Sanofi Synthelabo Research, Montpel- a variety of respiratory symptoms, including chronic cough and exacerbation of asthma. lier, France. In this study, the potential role of acid-induced tachykinin release was examined in guinea pigs and rabbits, by examining the effects of the tachykinin NK1 and NK3 Correspondence: C. Advenier receptors antagonists (SR 140333 and SR 142801, respectively) (1–10 mg?kg-1)on Universite´ Paris V plasma protein extravasation induced in airways by hydrochloric acid (HCl) infusion in UPRES EA220, Pharmacologie the oesophagus. 45 rue des Saints Pe`res Guinea pigs were anaesthetised with urethane, while rabbits were subject to F-75006 Paris neuroleptoanalgesia with hypnorm. Airway vascular leakage was evaluated by France Fax: 33 142863810 measuring extravasation of Evans blue dye. All animals were pretreated with atropine E-mail: [email protected] (1 mg?kg-1 i.p.), propranolol (1 mg?kg-1 i.p.), phosphoramidon (2.5 mg?kg-1 i.v.) and -1 saline or tachykinin receptor antagonists (1–10 mg?kg i.p.).
    [Show full text]
  • Neurotransmitters-Drugs Andbrain Function.Pdf
    Neurotransmitters, Drugs and Brain Function. Edited by Roy Webster Copyright & 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7 Neurotransmitters, Drugs and Brain Function Neurotransmitters, Drugs and Brain Function. Edited by Roy Webster Copyright & 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7 Neurotransmitters, Drugs and Brain Function Edited by R. A. Webster Department of Pharmacology, University College London, UK JOHN WILEY & SONS, LTD Chichester Á New York Á Weinheim Á Brisbane Á Singapore Á Toronto Neurotransmitters, Drugs and Brain Function. Edited by Roy Webster Copyright & 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7 Copyright # 2001 by John Wiley & Sons Ltd. Bans Lane, Chichester, West Sussex PO19 1UD, UK National 01243 779777 International ++44) 1243 779777 e-mail +for orders and customer service enquiries): [email protected] Visit our Home Page on: http://www.wiley.co.uk or http://www.wiley.com All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency Ltd, 90 Tottenham Court Road, London W1P0LP,UK, without the permission in writing of the publisher. Other Wiley Editorial Oces John Wiley & Sons, Inc., 605 Third Avenue, New York, NY 10158-0012, USA WILEY-VCH Verlag GmbH, Pappelallee 3, D-69469 Weinheim, Germany John Wiley & Sons Australia, Ltd.
    [Show full text]
  • Compositions for Treating Centrally Mediated
    (19) TZZ Z_T (11) EP 2 722 045 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/4178 (2006.01) A61K 31/473 (2006.01) 06.07.2016 Bulletin 2016/27 A61K 31/496 (2006.01) A61K 31/573 (2006.01) A61K 45/06 (2006.01) A61K 9/00 (2006.01) (2006.01) (2006.01) (21) Application number: 14151683.1 A61K 9/20 A61K 9/48 A61P 1/08 (2006.01) (22) Date of filing: 18.11.2010 (54) Compositions for treating centrally mediated nausea and vomiting Zusammensetzungen zur Behandlung von zentral vermitteltem Unwohlsein und Erbrechen Compositions pour traiter les nausées et vomissements à médiation centrale (84) Designated Contracting States: (56) References cited: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB WO-A1-2008/049552 WO-A2-2007/096763 GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR • REDDY G KESAVA ET AL: "Novel neurokinin-1 antagonists as antiemetics for the treatment of (30) Priority: 18.11.2009 US 262470 P chemotherapy-induced emesis.", SUPPORTIVE 14.09.2010 US 382709 P CANCER THERAPY 1 APR 2006 LNKD- PUBMED:18632487, vol. 3, no. 3, 1 April 2006 (43) Date of publication of application: (2006-04-01), pages140-142, XP002626039, ISSN: 23.04.2014 Bulletin 2014/17 1543-2912 • DIEMUNSCH P ET AL: "Neurokinin-1 receptor (62) Document number(s) of the earlier application(s) in antagonists in the prevention of postoperative accordance with Art.
    [Show full text]
  • Differential Regulation of Mecp2 Phosphorylation in the CNS by Dopamine and Serotonin
    Neuropsychopharmacology (2012) 37, 321–337 & 2012 American College of Neuropsychopharmacology. All rights reserved 0893-133X/12 www.neuropsychopharmacology.org Differential Regulation of MeCP2 Phosphorylation in the CNS by Dopamine and Serotonin 1 1 2 1,2,3,4 ,1 Ashley N Hutchinson , Jie V Deng , Dipendra K Aryal , William C Wetsel and Anne E West* 1 2 Department of Neurobiology, Duke University Medical Center, Durham, NC, USA; Department of Psychiatry and Behavioral Sciences, Duke 3 University Medical Center, Durham, NC, USA; Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, 4 Durham, NC, USA; Department of Cell Biology, Duke University Medical Center, Durham, NC, USA Systemic administration of amphetamine (AMPH) induces phosphorylation of MeCP2 at Ser421 (pMeCP2) in select populations of neurons in the mesolimbocortical brain regions. Because AMPH simultaneously activates multiple monoamine neurotransmitter systems, here we examined the ability of dopamine (DA), serotonin (5-HT), and norepinephrine (NE) to induce pMeCP2. Selective blockade of the DA transporter (DAT) or the 5-HT transporter (SERT), but not the NE transporter (NET), was sufficient to induce pMeCP2 in the CNS. DAT blockade induced pMeCP2 in the prelimbic cortex (PLC) and nucleus accumbens (NAc), whereas SERT blockade induced pMeCP2 only in the NAc. Administration of selective DA and 5-HT receptor agonists was also sufficient to induce pMeCP2; however, the specific combination of DA and 5-HT receptors activated determined the regional- and cell-type specificity of pMeCP2 induction. The D1-class DA receptor agonist SKF81297 induced pMeCP2 widely; however, coadministration of the D2-class agonist quinpirole restricted the induction of pMeCP2 to GABAergic interneurons of the NAc.
    [Show full text]
  • File Download
    Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord Elizabeth A. Gozal, Emory University Brannan E. O'Neill, Emory University Michael A. Sawchuk, Emory University Hong Zhu, Emory University Mallika Halder, Emory University Chou Ching-Chieh , Emory University Shawn Hochman, Emory University Journal Title: Frontiers in Neural Circuits Volume: Volume 8 Publisher: Frontiers | 2014-11-07, Pages 134-134 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.3389/fncir.2014.00134 Permanent URL: https://pid.emory.edu/ark:/25593/mr95r Final published version: http://dx.doi.org/10.3389/fncir.2014.00134 Copyright information: © 2014 Gozal, O'Neill, Sawchuk, Zhu, Halder, Chou and Hochman. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits distribution of derivative works, making multiple copies, distribution, public display, and publicly performance, provided the original work is properly cited. This license requires credit be given to copyright holder and/or author, copyright and license notices be kept intact. Accessed September 27, 2021 11:18 AM EDT ORIGINAL RESEARCH ARTICLE published: 07 November 2014 NEURAL CIRCUITS doi: 10.3389/fncir.2014.00134 Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord Elizabeth A. Gozal , Brannan E. O’Neill , Michael A. Sawchuk , Hong Zhu , Mallika Halder , Ching-Chieh Chou and Shawn Hochman* Physiology Department, Emory University, Atlanta, GA, USA Edited by: The trace amines (TAs), tryptamine, tyramine, and β-phenylethylamine, are synthesized Brian R.
    [Show full text]
  • MONTHLY TOTALS CITY of BIG LAKE Receipt T
    CITY OF BIG LAKE Receipt Register - MONTHLY TOTALS Page: 1 Receipt Dates: 03/01/2021 - 03/31/2021 Apr 29, 2021 11:06AM Workspace Receipt Customer Distribution Receipt Number Date Category Name Description V Amount Total CITY HALL COUNTE CITY HALL C 1.000718 03/01/2021 UTILITY BILLI MITCHELL, MICHAEL UTILITY PAYMENTS N 400.00 400.00 CITY HALL C 1.000719 03/01/2021 UTILITY BILLI MORTENSON, RICHARD UTILITY PAYMENTS N 93.55 93.55 CITY HALL C 1.000720 03/01/2021 UTILITY BILLI WOOLARD, PATRICK UTILITY PAYMENTS N 81.59 81.59 CITY HALL C 1.000721 03/01/2021 UTILITY BILLI PELVIT, LAWRENCE UTILITY PAYMENTS N 80.26 80.26 CITY HALL C 1.000722 03/01/2021 UTILITY BILLI KAMPA, DONALD UTILITY PAYMENTS N 53.68 53.68 CITY HALL C 1.000723 03/01/2021 POLICE JOHNSON, JESSICA A WINTER PARKING CITATION # 2210 CASE # 21001351 Y 50.00 50.00 CITY HALL C 1.000724 03/01/2021 POLICE JOHNSON, JESSICA A Voids receipt - 1.000723 Y 50.00- 50.00- CITY HALL C 1.000725 03/01/2021 POLICE JOHNSON, JESSICA A WINTER PARKING CITATION # 2210 CASE # 21001351 N 50.00 50.00 CITY HALL C 1.000726 03/01/2021 ACCOUNTS R SAENGER, MILES OLSON & KELLY SNOW REMOVAL INV # 2021-0062 N 40.00 40.00 CITY HALL C 1.000727 03/01/2021 POLICE FREUND, MARGARET POLICE FINGERPRINTING N 25.00 25.00 CITY HALL C 1.000728 03/01/2021 POLICE CASH POLICE ADMIN CITE VEH RELEASE CASE # 21001670 N 50.00 50.00 CITY HALL C 1.000729 03/01/2021 UTILITY BILLI BIG LAKE CLINIC UTILITY PAYMENTS N 692.08 CITY HALL C ACCOUNTS R CENTRACARE CLINIC - BIG LAKE SNOW REMOVAL INV # 2021-0068 N 175.00 867.08 CITY HALL C 1.000730
    [Show full text]
  • Family Group Sheets Surname Index
    PASSAIC COUNTY HISTORICAL SOCIETY FAMILY GROUP SHEETS SURNAME INDEX This collection of 660 folders contains over 50,000 family group sheets of families that resided in Passaic and Bergen Counties. These sheets were prepared by volunteers using the Societies various collections of church, ceme tery and bible records as well as city directo ries, county history books, newspaper abstracts and the Mattie Bowman manuscript collection. Example of a typical Family Group Sheet from the collection. PASSAIC COUNTY HISTORICAL SOCIETY FAMILY GROUP SHEETS — SURNAME INDEX A Aldous Anderson Arndt Aartse Aldrich Anderton Arnot Abbott Alenson Andolina Aronsohn Abeel Alesbrook Andreasen Arquhart Abel Alesso Andrews Arrayo Aber Alexander Andriesse (see Anderson) Arrowsmith Abers Alexandra Andruss Arthur Abildgaard Alfano Angell Arthurs Abraham Alje (see Alyea) Anger Aruesman Abrams Aljea (see Alyea) Angland Asbell Abrash Alji (see Alyea) Angle Ash Ack Allabough Anglehart Ashbee Acker Allee Anglin Ashbey Ackerman Allen Angotti Ashe Ackerson Allenan Angus Ashfield Ackert Aller Annan Ashley Acton Allerman Anners Ashman Adair Allibone Anness Ashton Adams Alliegro Annin Ashworth Adamson Allington Anson Asper Adcroft Alliot Anthony Aspinwall Addy Allison Anton Astin Adelman Allman Antoniou Astley Adolf Allmen Apel Astwood Adrian Allyton Appel Atchison Aesben Almgren Apple Ateroft Agar Almond Applebee Atha Ager Alois Applegate Atherly Agnew Alpart Appleton Atherson Ahnert Alper Apsley Atherton Aiken Alsheimer Arbuthnot Atkins Aikman Alterman Archbold Atkinson Aimone
    [Show full text]
  • Modifications to the Harmonized Tariff Schedule of the United States To
    U.S. International Trade Commission COMMISSIONERS Shara L. Aranoff, Chairman Daniel R. Pearson, Vice Chairman Deanna Tanner Okun Charlotte R. Lane Irving A. Williamson Dean A. Pinkert Address all communications to Secretary to the Commission United States International Trade Commission Washington, DC 20436 U.S. International Trade Commission Washington, DC 20436 www.usitc.gov Modifications to the Harmonized Tariff Schedule of the United States to Implement the Dominican Republic- Central America-United States Free Trade Agreement With Respect to Costa Rica Publication 4038 December 2008 (This page is intentionally blank) Pursuant to the letter of request from the United States Trade Representative of December 18, 2008, set forth in the Appendix hereto, and pursuant to section 1207(a) of the Omnibus Trade and Competitiveness Act, the Commission is publishing the following modifications to the Harmonized Tariff Schedule of the United States (HTS) to implement the Dominican Republic- Central America-United States Free Trade Agreement, as approved in the Dominican Republic-Central America- United States Free Trade Agreement Implementation Act, with respect to Costa Rica. (This page is intentionally blank) Annex I Effective with respect to goods that are entered, or withdrawn from warehouse for consumption, on or after January 1, 2009, the Harmonized Tariff Schedule of the United States (HTS) is modified as provided herein, with bracketed matter included to assist in the understanding of proclaimed modifications. The following supersedes matter now in the HTS. (1). General note 4 is modified as follows: (a). by deleting from subdivision (a) the following country from the enumeration of independent beneficiary developing countries: Costa Rica (b).
    [Show full text]
  • Selective Blockade of NK2 Or NK3 Receptors Produces Anxiolytic- and Antidepressant-Like Effects in Gerbils ⁎ N
    Pharmacology, Biochemistry and Behavior 83 (2006) 533–539 www.elsevier.com/locate/pharmbiochembeh Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils ⁎ N. Salomé, J. Stemmelin, C. Cohen , G. Griebel Sanofi-Aventis, Department of Psychopharmacology, 31 av Paul Vaillant-Couturier, 92220 Bagneux, France Received 17 October 2005; received in revised form 1 March 2006; accepted 9 March 2006 Available online 19 April 2006 Abstract There is a growing interest in the potential anxiolytic- and antidepressant-like effects of compounds that target neurokinin receptors. Since the structure and the pharmacology of the human neurokinin receptor resembles that of gerbils, rather than that of mice or rats, we decided to investigate the anxiolytic- and /or antidepressant-like effects of NK1 (SSR240600), NK2 (saredutant) and NK3 (osanetant) receptor antagonists in gerbils. It was found that saredutant (3–10 mg/kg, p.o.) and osanetant (3–10 mg/kg, p.o.) produced anxiolytic-like effects in the gerbil social interaction test. These effects were similar to those obtained with the V1b receptor antagonist SSR149415 (3–10 mg/kg, p.o.), diazepam (1 mg/kg, p.o.) and buspirone (10 mg/kg, p.o.). Fluoxetine and SSR240600 were devoid of effects in this test. In the tonic immobility test in gerbils, saredutant (5–10 mg/kg, i.p.) and osanetant (5–10 mg/kg, i.p.) produced similar effects to those observed with fluoxetine (7.5–15 mg/kg, i.p.), SSR149415 (10–30 mg/kg, p.o.) and buspirone (3 mg/kg, i.p.). Diazepam and SSR240600 were inactive in this paradigm.
    [Show full text]